文献速递运动医学关节外科

术后富血小板血浆注射对关节镜下冈上肌修复的中期评估:一项随机对照试验

A Midterm Evaluation of Postoperative Platelet-Rich Plasma Injections on Arthroscopic Supraspinatus Repair: A Randomized Controlled Trial.
PubMed 文献 · Am J Sports Med · 2017-08-14

这项随机对照试验将60例关节镜下冈上肌双排修复患者分为对照组与PRP组,PRP组在术后第7天和第14天接受2次超声引导下富血小板血浆注射。55例患者平均随访3.5年,两组患者报告结局指标均无差异,PRP组Constant力量子量表评分显著更高(3.3分;95%CI,1.0-5.7;P=.006),但MRI评分和再撕裂率无组间差异。

要点

  • 术后第7天和第14天重复注射PRP未改善冈上肌修复的中期肌腱完整性。
  • PRP组Constant力量子量表评分显著高于对照组(3.3分;95%CI,1.0-5.7;P=.006)。
  • 两组患者报告结局指标、MRI评分及再撕裂率均无显著差异。

核心结论

  • 冈上肌修复术后中期随访观察到显著的临床改善和高水平患者满意度。
  • 虽然PRP治疗后中期无痛最大外展力量更大,但术后第7天和第14天重复应用PRP对肌腱完整性未提供额外获益。

研究设计与样本

  • 随机对照试验,证据等级1级。
  • 共60例患者(对照组30例;PRP组30例)被随机分配,PRP组在双排关节镜下冈上肌修复术后第7天和第14天接受2次超声引导下注射PRP至肌腱修复部位。
  • 55例患者(91.7%)在术后平均3.5年(范围36-51个月)接受了临床复查和磁共振成像(MRI)。

主要发现

  • 中期复查时,两组间任何患者报告结局指标均无差异。
  • Constant评分的主观和活动度子量表无组间差异,但PRP组Constant力量子量表评分显著更高(3.3分;95%CI,1.0-5.7;P=.006)。
  • MRI评分或再撕裂率无组间差异证据,PRP组66.7%和对照组64.3%的患者被评为Sugaya 1级。
  • 对照组2例患者在术后前16周内出现症状性再撕裂(均为全层),PRP组2例患者在16周至平均3.5年随访期间出现症状性再撕裂(均为部分层厚)。

关键数值与推荐

  • PRP组Constant力量子量表评分较对照组高3.3分(95%CI,1.0-5.7;P=.006)。
  • PRP组66.7%的患者和对照组64.3%的患者MRI评估为Sugaya 1级。
  • 对照组2例症状性再撕裂(均为全层)发生在术后前16周内;PRP组2例症状性再撕裂(均为部分层厚)发生在16周至平均3.5年随访期间。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Platelet-rich plasma (PRP) has been applied as an adjunct to rotator cuff repair to improve tendon-bone healing and potentially reduce the incidence of subsequent tendon retears. PURPOSE: To investigate whether the midterm clinical and radiographic outcomes of arthroscopic supraspinatus repair are enhanced after repeated postoperative applications of PRP. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: A total of 60 patients (30 control; 30 PRP) were initially randomized to receive 2 ultrasound-guided injections of PRP to the tendon repair site at 7 and 14 days after double-row arthroscopic supraspinatus repair or not. A total of 55 patients (91.7%) underwent a clinical review and magnetic resonance imaging (MRI) at a mean of 3.5 years after surgery (range, 36-51 months). Patient-reported outcome measures (PROMs) included the Constant score, Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire, Oxford Shoulder Score (OSS), and visual analog scale (VAS) for pain. Global rating of change (GRC) scale and patient satisfaction scores were evaluated. Structural integrity of the surgical repair was assessed via MRI using the Sugaya classification system. RESULTS: At the midterm review, there was no difference between the groups for any of the PROMs. No differences between the groups were demonstrated for the subjective and range of motion subscales of the Constant score, although a significantly higher Constant strength subscale score was observed in the PRP group (3.3 points; 95% CI, 1.0-5.7; P = .006). There was no evidence for any group differences in MRI scores or retear rates, with 66.7% of PRP patients and 64.3% of control patients rated as Sugaya grade 1. Two control patients had symptomatic retears (both full thickness) within the first 16 weeks after surgery compared with 2 PRP patients, who suffered symptomatic retears (both partial thickness) between 16 weeks and a mean 3.5-year follow-up. CONCLUSION: Significant postoperative clinical improvements and high levels of patient satisfaction were observed in patients at the midterm review after supraspinatus repair. While pain-free, maximal abduction strength was greater in the midterm after PRP treatment, repeated applications of PRP delivered at 7 and 14 days after surgery provided no additional benefit to tendon integrity.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Ebert JR, Wang A, Smith A, et al. A Midterm Evaluation of Postoperative Platelet-Rich Plasma Injections on Arthroscopic Supraspinatus Repair: A Randomized Controlled Trial. Am J Sports Med. 2017. PMID: 28806095. doi:10.1177/0363546517719048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。